Financials Eramet

Equities

ERA

FR0000131757

Diversified Mining

Market Closed - Euronext Paris 11:36:23 2024-05-17 am EDT 5-day change 1st Jan Change
101.3 EUR +0.60% Intraday chart for Eramet -0.59% +41.68%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,217 1,136 2,064 2,227 2,041 2,886 - -
Enterprise Value (EV) 1 2,521 2,469 3,000 2,571 2,041 3,566 3,314 2,826
P/E ratio -6.61 x -1.69 x 6.9 x 3.25 x 18.9 x 12.2 x 4.98 x 4.79 x
Yield - - 3.47% 4.17% - 1.97% 2.66% 3.95%
Capitalization / Revenue 0.33 x 0.32 x 0.56 x 0.44 x 0.63 x 0.78 x 0.67 x 0.65 x
EV / Revenue 0.69 x 0.69 x 0.82 x 0.51 x 0.63 x 0.96 x 0.77 x 0.64 x
EV / EBITDA 4 x 6.2 x 2.85 x 1.66 x 5.88 x 3.97 x 3.16 x 2.07 x
EV / FCF -7.48 x -48.4 x 7.48 x 4.39 x - -7.74 x 37.4 x 4.5 x
FCF Yield -13.4% -2.07% 13.4% 22.8% - -12.9% 2.67% 22.2%
Price to Book 0.87 x 1.49 x 1.89 x 1.37 x - 1.52 x 1.2 x 1 x
Nbr of stocks (in thousands) 26,541 26,459 28,683 26,558 28,542 28,493 - -
Reference price 2 45.84 42.92 71.95 83.85 71.50 101.3 101.3 101.3
Announcement Date 2/19/20 2/16/21 2/23/22 2/22/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,671 3,553 3,668 5,014 3,251 3,697 4,331 4,407
EBITDA 1 630 398 1,051 1,553 347 897.5 1,048 1,362
EBIT 1 223 106 784 1,280 127 542 760.9 790.2
Operating Margin 6.07% 2.98% 21.37% 25.53% 3.91% 14.66% 17.57% 17.93%
Earnings before Tax (EBT) 1 82 -555 889 1,194 100 377.1 1,294 1,350
Net income 1 -184 -675 298 740 109 147.6 468.5 604
Net margin -5.01% -19% 8.12% 14.76% 3.35% 3.99% 10.82% 13.7%
EPS 2 -6.930 -25.46 10.42 25.81 3.790 8.330 20.36 21.13
Free Cash Flow 1 -337 -51 401 586 - -460.8 88.55 628.3
FCF margin -9.18% -1.44% 10.93% 11.69% - -12.46% 2.04% 14.26%
FCF Conversion (EBITDA) - - 38.15% 37.73% - - 8.45% 46.12%
FCF Conversion (Net income) - - 134.56% 79.19% - - 18.9% 104.02%
Dividend per Share 2 - - 2.500 3.500 - 1.995 2.697 4.000
Announcement Date 2/19/20 2/16/21 2/23/22 2/22/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 Q1 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 1,862 1,687 1,866 1,878 1,790 2,635 2,379 775 1,604 1,647 1,682 2,144
EBITDA 323 120 278 293 758 982 571 - 339 - 355 750
EBIT 54 -32 137 159 625 853 427 - - - 74 403
Operating Margin 2.9% -1.9% 7.34% 8.47% 34.92% 32.37% 17.95% - - - 4.4% 18.8%
Earnings before Tax (EBT) - - - - - - - - - - - -
Net income - -623 -52 53 - 677 - - - - 31 269
Net margin - -36.93% -2.79% 2.82% - 25.69% - - - - 1.84% 12.55%
EPS - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - -
Announcement Date 2/19/20 7/29/20 2/16/21 7/28/21 2/23/22 7/27/22 2/22/23 4/27/23 7/26/23 2/21/24 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,304 1,333 936 344 - 679 427 -
Net Cash position 1 - - - - - - - 60.8
Leverage (Debt/EBITDA) 2.07 x 3.349 x 0.8906 x 0.2215 x - 0.7568 x 0.4078 x -
Free Cash Flow 1 -337 -51 401 586 - -461 88.6 628
ROE (net income / shareholders' equity) -4.39% -62.4% 26% 51% - 11.8% 20.7% 19.9%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share 2 52.70 28.90 38.10 61.30 - 66.80 84.40 102.0
Cash Flow per Share 2 3.240 11.70 24.90 38.90 - 8.770 22.50 49.50
Capex 1 423 360 312 530 - 920 713 477
Capex / Sales 11.52% 10.13% 8.51% 10.57% - 24.88% 16.46% 10.83%
Announcement Date 2/19/20 2/16/21 2/23/22 2/22/23 2/21/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
101.3 EUR
Average target price
134.4 EUR
Spread / Average Target
+32.68%
Consensus

Quarterly revenue - Rate of surprise

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW